Canada Life’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-668
Closed -$13K 2804
2018
Q3
$13K Hold
668
﹤0.01% 2532
2018
Q2
$38K Hold
668
﹤0.01% 2455
2018
Q1
$28K Hold
668
﹤0.01% 2471
2017
Q4
$36K Hold
668
﹤0.01% 2428
2017
Q3
$30K Hold
668
﹤0.01% 2438
2017
Q2
$32K Sell
668
-44,135
-99% -$2.6M ﹤0.01% 2436
2017
Q1
$3.25M Buy
44,803
+44,135
+6,607% +$2.92M 0.01% 852
2016
Q4
$38K Hold
668
﹤0.01% 2385
2016
Q3
$85K Hold
668
﹤0.01% 2198
2016
Q2
$83K Hold
668
﹤0.01% 2173
2016
Q1
$56K Hold
668
﹤0.01% 2081
2015
Q4
$66K Hold
668
﹤0.01% 2029
2015
Q3
$82K Sell
668
-16,240
-96% -$2.2M ﹤0.01% 1842
2015
Q2
$2.59M Buy
16,908
+1,210
+8% +$200K 0.01% 755
2015
Q1
$2.67M Buy
15,698
+771
+5% +$117K 0.01% 746
2014
Q4
$2.29M Buy
14,927
+5,170
+53% +$645K 0.01% 760
2014
Q3
$1.03M Buy
9,757
+9,510
+3,850% +$1.33M ﹤0.01% 883
2014
Q2
$37K Hold
247
﹤0.01% 2085
2014
Q1
$32K Hold
247
﹤0.01% 2017
2013
Q4
$43K Buy
+247
New +$42.4K ﹤0.01% 1890

Other funds holding ELGX

Canada Life's ELGX Position: Q4 2018 in Review

Canada Life sold out of Endologix Inc (ELGX) in Q4 2018, closing a stake of 668 shares — an estimated $13K sold.

Canada Life first reported a position in ELGX in Q4 2013 and held it in 20 quarters. The position peaked at $3.25M in Q1 2017. 99 funds tracked by Wall St. Rank hold ELGX as of Q4 2018.

  • Canada Life reported no remaining Endologix Inc position as of Q4 2018 after selling out during the quarter.
  • Canada Life sold 668 Endologix Inc shares in Q4 2018, an estimated $13K.
  • Canada Life first reported a position in Endologix Inc in Q4 2013 and held it in 20 quarters.
  • Canada Life's Endologix Inc position peaked at $3.25M in Q1 2017.
  • 99 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2018.

Based on Canada Life's 13F filing for Q4 2018, filed 12 Feb 2019.